Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Genetics
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 1-6 of 6 total displayed.

Most recent content (1 Aug 2009):

Original Articles
CACNA1C Gene Polymorphisms, Cardiovascular Disease Outcomes, and Treatment Response
Amber L. Beitelshees, Hrishikesh Navare, Danxin Wang, Yan Gong, Jennifer Wessel, James I. Moss, Taimour Y. Langaee, Rhonda M. Cooper-DeHoff, Wolfgang Sadee, Carl J. Pepine, Nicolas J. Schork, and Julie A. Johnson
Circ Cardiovasc Genet 2009;2:362-370; published online before print as doi:10.1161/CIRCGENETICS.109.857839 [Abstract] [Full text]  

Past content (since Dec 2008):

Original Article
CACNA1C gene polymorphisms, cardiovascular disease outcomes and treatment response
Amber L. Beitelshees, Hrishikesh Navare, Danxin Wang, Yan Gong, Jennifer Wessel, James Moss, Taimour Y. Langaee, Rhonda M. Cooper–DeHoff, Wolfgang Sadee, Carl J. Pepine, Nicolas J. Schork, and Julie A. Johnson
Circ Cardiovasc Genet published June 3, 2009, doi:10.1161/CIRCGENETICS.109.857839 [Abstract]  

Original Articles
The FTO Gene Is Associated With an Atherogenic Lipid Profile and Myocardial Infarction in Patients With Type 2 Diabetes: A Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) Study
Alex S.F. Doney, Jennifer Dannfald, Charlotte H. Kimber, Louise A. Donnelly, Ewan Pearson, Andrew D. Morris, and Colin N.A. Palmer
Circ Cardiovasc Genet 2009;2:255-259; published online before print as doi:10.1161/CIRCGENETICS.108.822320 [Abstract] [Full text]  

Original Article
The FTO Gene is Associated with an Atherogenic Lipid Profile and Myocardial Infarction in Patients with Type 2 Diabetes: A Go-DARTS study.
Alexander S.F. Doney, Jennifer Dannfald, Charlotte H. Kimber, Louise A. Donnelly, Ewan Pearson, Andrew D. Morris, and Colin N.A. Palmer
Circ Cardiovasc Genet published March 30, 2009, doi:10.1161/CIRCGENETICS.108.822320 [Abstract]  

Original Article
Pharmacogenetic predictors of statin mediated LDLc reduction and dose response
Deepak Voora, Svati H. Shah, Carol R. Reed, Jun Zhai, David R. Crosslin, Chad J. Messer, Benjamin A. Salisbury, and Geoffrey S. Ginsburg
Circ Cardiovasc Genet published December 9, 2008, doi:10.1161/CIRCGENETICS.108.795013 [Abstract]  

Original Articles
Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response
Deepak Voora, Svati H. Shah, Carol R. Reed, Jun Zhai, David R. Crosslin, Chad Messer, Benjamin A. Salisbury, and Geoffrey S. Ginsburg
Circ Cardiovasc Genet 2008;1:100-106; published online before print as doi:10.1161/CIRCGENETICS.108.795013 [Abstract] [Full text]  

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment